Courses · Gurbir Gill, MD

Endocrine Deep Dives

by Gurbir Gill, MD

The Endocrine Deep Dive covers advanced topics in endocrinology. Utilizing AI-driven synthetic audio discussions from my own study notes, each episode breaks down complex endocrine concepts. Comprehensive Legal & Medical Disclaimer: Endocrine Deep Dives and all associated content, materials, and digital assets are produced strictly for informational and educational purposes only. The program is intended solely for healthcare providers, medical fellows, residents, and students as a supplement to their professional training. No Physician-Patient Relationship: Listening to this podcast, accessing show notes, or interacting with the platform does not establish a physician-patient, pharmacist-patient, or any other formal professional-client relationship between the host and any listener or patient. Not Medical Advice: The content does not constitute individualized medical advice, clinical diagnosis, or treatment recommendations. Patients and members of the general public must never use this content to guide personal healthcare decisions and must always consult a qualified, licensed physician or healthcare provider for any medical concerns. Clinical Responsibility: Healthcare professionals listening to this program must exercise their own independent clinical judgment. The host's interpretations, study notes, and opinions reflect personal perspectives on literature and do not set an official standard of care. Clinicians bear sole responsibility for verifying all pharmacological dosing, diagnostic criteria, and treatment protocols against official institutional guidelines, current primary literature, and individual patient presentation. Limitation of Liability: The host, creators, and associated entities disclaim any and all liability for direct, indirect, incidental, or consequential damages resulting from the use, misuse, application, or interpretation of any information presented in this podcast. Reliance on any data or opinion provided is solely at the listener's own risk.

Latest episodes

Showing 20 · updated from the feed

Emil Theodor Kocher

Emil Theodor Kocher revolutionized endocrine surgery by developing meticulous, sterile, and bloodless thyroidectomy techniques. His standardized operative methods reduced

Nov 2
27 min

Calcitonin

Calcitonin, secreted by thyroid parafollicular C cells, acts as a physiological antagonist to parathyroid hormone by suppressing osteoclastic bone resorption and renal tu

Oct 30
24 min

Multiple Endocrine Neoplasia Type 1

Multiple endocrine neoplasia type 1 arises from inactivating MEN1 tumor suppressor mutations, causing loss of menin function. Clinical manifestations classically feature

Oct 29
20 min

Crinecerfont for Steroid Reduction in CAH

This episode evaluates crinecerfont, an oral corticotropin-releasing factor type 1 receptor antagonist, for classic congenital adrenal hyperplasia. By blocking pituitary

Oct 28
21 min

XLH and Burosumab

Adult presentations frequently masquerade as axial spondyloarthritis, early-onset osteoarthritis, or recurrent pseudofractures, evading diagnosis when chronic hypophospha

Oct 27
21 min

Billing Code CGM/95251

Analysis and interpretation of continuous glucose monitoring data requiring at least seventy-two hours of sensor wear. This physician service focuses on evaluating glycem

Oct 27
17 min

Billing Code G2211

Explore the clinical implementation of add-on code G2211 for longitudinal endocrinology outpatient care. We analyze Centers for Medicare and Medicaid Services documentati

Oct 27
16 min

COCPs for PMOS

Combined oral contraceptives serve as first-line pharmacotherapy for non-fertility management. They suppress pituitary luteinizing hormone secretion to arrest ovarian the

Oct 23
24 min

Mixed Meal Tolerance Test

A physiological dynamic assessment evaluating beta-cell secretory capacity and postprandial glycemic regulation under mixed macronutrient stimulation. Crucial for assessi

Oct 22
18 min

Denosumab risks in CKD

Denosumab carries a marked risk of profound, refractory hypocalcemia in advanced chronic kidney disease, particularly stages 4 to 5D and comorbid CKD-mineral and bone dis

Oct 21
22 min

Outpatient management of DKA

Outpatient management of diabetic ketoacidosis is inherently limited to early intervention during impending ketosis, as overt DKA with metabolic acidosis and volume deple

Oct 20
21 min

MACS

Mild autonomous cortisol secretion, or MACS, represents subtle hypothalamic-pituitary-adrenal axis dysregulation most frequently encountered during the workup of adrenal

Oct 19
14 min

Familial hyperaldosteronism type 2

Familial hyperaldosteronism type 2 is an autosomal dominant form of primary aldosteronism caused predominantly by gain-of-function mutations in the CLCN2 gene, which enco

Oct 16
23 min

Phosphopenic Osteomalacia

Phosphopenic disorders encompass conditions characterized by systemic phosphate wasting or deficiency, driven primarily by renal tubular defects, fibroblast growth factor

Oct 15
21 min

Calcipenic Osteomalacia

Calcipenic osteomalacia presents with low-to-normal calcium, elevated PTH, hypophosphatemia, elevated alkaline phosphatase, and low urinary calcium. Evaluation requires r

Oct 14
25 min

Calcipenic and Phosphopenic Osteomalacia

Calcipenic osteomalacia arises primarily from vitamin D deficiency or resistance, or severe calcium malabsorption, resulting in impaired mineralization due to defective i

Oct 13
20 min

Vitamin D Formulations

Clinical management of vitamin D deficiency requires distinguishing between native secosteroids and hydroxylated metabolites based on individual metabolic clearance and o

Oct 12
20 min

Teprotumumab

Teprotumumab is a fully human monoclonal antibody targeting the insulin-like growth factor 1 receptor, revolutionizing the medical management of active thyroid eye diseas

Oct 8
21 min

Fragile X Premutation

Fragile X premutation carriers harbor FMR1 allele expansions containing fifty-five to two hundred CGG repeats, predisposing them to distinct clinical syndromes driven by

Oct 7
21 min

Bone Turnover Markers

PODCAST SUMMARY: Bone turnover markers provide dynamic, real-time biochemical assessment of skeletal metabolism by quantifying bone formation through serum osteocalcin an

Oct 6
22 min